191 related articles for article (PubMed ID: 17455969)
1. Mass spectrometric analysis of high-mobility group proteins and their post-translational modifications in normal and cancerous human breast tissues.
Zou Y; Wang Y
J Proteome Res; 2007 Jun; 6(6):2304-14. PubMed ID: 17455969
[TBL] [Abstract][Full Text] [Related]
2. Tandem mass spectrometry for the examination of the posttranslational modifications of high-mobility group A1 proteins: symmetric and asymmetric dimethylation of Arg25 in HMGA1a protein.
Zou Y; Wang Y
Biochemistry; 2005 Apr; 44(16):6293-301. PubMed ID: 15835918
[TBL] [Abstract][Full Text] [Related]
3. In vivo posttranslational modifications of the high mobility group A1a proteins in breast cancer cells of differing metastatic potential.
Edberg DD; Bruce JE; Siems WF; Reeves R
Biochemistry; 2004 Sep; 43(36):11500-15. PubMed ID: 15350136
[TBL] [Abstract][Full Text] [Related]
4. Dynamic and differential in vivo modifications of the isoform HMGA1a and HMGA1b chromatin proteins.
Edberg DD; Adkins JN; Springer DL; Reeves R
J Biol Chem; 2005 Mar; 280(10):8961-73. PubMed ID: 15591590
[TBL] [Abstract][Full Text] [Related]
5. A mass spectrometric study on the in vitro methylation of HMGA1a and HMGA1b proteins by PRMTs: methylation specificity, the effect of binding to AT-rich duplex DNA, and the effect of C-terminal phosphorylation.
Zou Y; Webb K; Perna AD; Zhang Q; Clarke S; Wang Y
Biochemistry; 2007 Jul; 46(26):7896-906. PubMed ID: 17550233
[TBL] [Abstract][Full Text] [Related]
6. Human KIT ligand promoter is positively regulated by HMGA1 in breast and ovarian cancer cells.
Treff NR; Dement GA; Adair JE; Britt RL; Nie R; Shima JE; Taylor WE; Reeves R
Oncogene; 2004 Nov; 23(52):8557-62. PubMed ID: 15378028
[TBL] [Abstract][Full Text] [Related]
7. Acetylation and phosphorylation of high-mobility group A1 proteins in PC-3 human tumor cells.
Jiang X; Wang Y
Biochemistry; 2006 Jun; 45(23):7194-201. PubMed ID: 16752910
[TBL] [Abstract][Full Text] [Related]
8. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin.
Sharma A; Ray R; Rajeswari MR
Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743
[TBL] [Abstract][Full Text] [Related]
9. Interaction of adriamycin with a promoter region of hmga1 and its inhibitory effect on HMGA1 expression in A431 human squamous carcinoma cell line.
Akhter MZ; Sharma A; Rajeswari MR
Mol Biosyst; 2011 Apr; 7(4):1336-46. PubMed ID: 21336378
[TBL] [Abstract][Full Text] [Related]
10. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.
Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G
J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492
[TBL] [Abstract][Full Text] [Related]
11. The canine HMGA1.
Murua Escobar H; Soller JT; Richter A; Meyer B; Winkler S; Flohr AM; Nolte I; Bullerdiek J
Gene; 2004 Apr; 330():93-9. PubMed ID: 15087128
[TBL] [Abstract][Full Text] [Related]
12. A quantitative study on the in vitro and in vivo acetylation of high mobility group A1 proteins.
Zhang Q; Zhang K; Zou Y; Perna A; Wang Y
J Am Soc Mass Spectrom; 2007 Sep; 18(9):1569-78. PubMed ID: 17627840
[TBL] [Abstract][Full Text] [Related]
13. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
Masciullo V; Baldassarre G; Pentimalli F; Berlingieri MT; Boccia A; Chiappetta G; Palazzo J; Manfioletti G; Giancotti V; Viglietto G; Scambia G; Fusco A
Carcinogenesis; 2003 Jul; 24(7):1191-8. PubMed ID: 12807722
[TBL] [Abstract][Full Text] [Related]
15. Homeodomain-interacting protein kinase-2 (HIPK2) phosphorylates HMGA1a at Ser-35, Thr-52, and Thr-77 and modulates its DNA binding affinity.
Zhang Q; Wang Y
J Proteome Res; 2007 Dec; 6(12):4711-9. PubMed ID: 17960875
[TBL] [Abstract][Full Text] [Related]
16. High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells.
Treff NR; Pouchnik D; Dement GA; Britt RL; Reeves R
Oncogene; 2004 Jan; 23(3):777-85. PubMed ID: 14737112
[TBL] [Abstract][Full Text] [Related]
17. During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometry.
Sgarra R; Diana F; Bellarosa C; Dekleva V; Rustighi A; Toller M; Manfioletti G; Giancotti V
Biochemistry; 2003 Apr; 42(12):3575-85. PubMed ID: 12653562
[TBL] [Abstract][Full Text] [Related]
18. Differential HMGA expression and post-translational modifications in prostatic tumor cells.
Diana F; Di Bernardo J; Sgarra R; Tessari MA; Rustighi A; Fusco A; Giancotti V; Manfioletti G
Int J Oncol; 2005 Feb; 26(2):515-20. PubMed ID: 15645138
[TBL] [Abstract][Full Text] [Related]
19. Mapping of lysine monomethylation of linker histones in human breast and its cancer.
Lu A; Zougman A; Pudełko M; Bebenek M; Ziółkowski P; Mann M; Wiśniewski JR
J Proteome Res; 2009 Sep; 8(9):4207-15. PubMed ID: 19552482
[TBL] [Abstract][Full Text] [Related]
20. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.
Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ
J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
